COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2025.

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

The freeze-dried formulation will be easier to store and transport than the liquid-frozen formulation that Bavarian Nordic ...

Bavarian Nordic has supplied a liquid-frozen formulation of JYNNEOS to the U.S. government for stockpiling since 2010 and in ...

The Allan Labor Government is protecting more Victorians from mpox, making free vaccines widely available at four new vaccination sites across ...

GEO-CM04S1 Demonstrates Robust COVID-19 and Mpox Immunogenicity in Immunocompromised Patients and Healthy Adults ATLANTA, GA ...

A study in European Heart Journal yesterday shows a 23% lower risk of cardiovascular events in recipients of the shingles ...

Danish drugmaker Bavarian Nordic – which produces a vaccine sold under the Jynneos/Imvanex/Imvamune names – has also pledged 40,000 doses to the ongoing response, although experts have ...

Bavarian Nordic's Jynneos/Imvanex/Imvamune is approved in the US, Europe, and Canada, while KM Biologics' LC16 vaccine is available in Japan and Emergent BioSolutions' ACAM2000 is under regulatory ...